CytoSorbents Corp. (CTSO)
0.3356
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
0.341
+0.01
(+1.61%)
After-Hours: 20:00
CytoSorbents Free Cash Flow : -9.583M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.583M |
| March 31, 2026 | -10.59M |
| December 31, 2025 | -12.87M |
| September 30, 2025 | -10.14M |
| June 30, 2025 | -10.38M |
| March 31, 2025 | -13.65M |
| December 31, 2024 | -15.10M |
| September 30, 2024 | -19.18M |
| June 30, 2024 | -21.88M |
| March 31, 2024 | -23.76M |
| December 31, 2023 | -22.59M |
| September 30, 2023 | -21.59M |
| June 30, 2023 | -23.58M |
| March 31, 2023 | -29.51M |
| December 31, 2022 | -34.69M |
| September 30, 2022 | -36.31M |
| June 30, 2022 | -34.01M |
| March 31, 2022 | -24.30M |
| December 31, 2021 | -18.29M |
| September 30, 2021 | -12.45M |
| June 30, 2021 | -10.98M |
| March 31, 2021 | -6.522M |
| December 31, 2020 | -7.290M |
| September 30, 2020 | -10.49M |
| June 30, 2020 | -12.33M |
| Date | Value |
|---|---|
| March 31, 2020 | -17.29M |
| December 31, 2019 | -18.28M |
| September 30, 2019 | -16.78M |
| June 30, 2019 | -14.17M |
| March 31, 2019 | -14.40M |
| December 31, 2018 | -12.36M |
| September 30, 2018 | -10.32M |
| June 30, 2018 | -10.13M |
| March 31, 2018 | -8.626M |
| December 31, 2017 | -8.139M |
| September 30, 2017 | -8.325M |
| June 30, 2017 | -8.257M |
| March 31, 2017 | -8.147M |
| December 31, 2016 | -7.326M |
| September 30, 2016 | -8.555M |
| June 30, 2016 | -8.350M |
| March 31, 2016 | -8.471M |
| December 31, 2015 | -9.652M |
| September 30, 2015 | -9.907M |
| June 30, 2015 | -9.448M |
| March 31, 2015 | -8.752M |
| December 31, 2014 | -7.028M |
| September 30, 2014 | -5.635M |
| June 30, 2014 | -4.214M |
| March 31, 2014 | -3.720M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.824B |
| AngioDynamics, Inc. | -2.86M |
| Alphatec Holdings, Inc. | -5.739M |
| AtriCure, Inc. | 53.11M |
| Baxter International, Inc. | 812.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.583M |
| Cash from Investing (Quarterly) | 0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.0101 |
| Free Cash Flow to Equity (Quarterly) | -1.075M |
| Free Cash Flow to Firm (Quarterly) | 0.233M |
| Free Cash Flow Yield | -45.49% |